• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型 和 基因点突变与伊曲康唑和泊沙康唑耐药的 分离株相关。

Novel Point Mutations in and Genes Associated with Itraconazole and Posaconazole Resistance in Isolates.

机构信息

1 Invasive Fungi Research Center (IFRC), School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.

2 Department of Medical Mycology, Mazandaran University of Medical Sciences, Sari, Iran.

出版信息

Microb Drug Resist. 2019 Jun;25(5):652-662. doi: 10.1089/mdr.2018.0300. Epub 2019 Jan 18.

DOI:10.1089/mdr.2018.0300
PMID:30657433
Abstract

is a common environmental species known to cause occupational allergic disease in grain handlers. We have recently observed azole-resistant isolates of this fungus as a cause of onychomycosis. To further characterize the cause of resistance, the genes encoding 14 α-sterol demethylase enzyme ( and ) were characterized and analyzed in 9 ITC-susceptible isolates and 6 isolates with high minimum inhibitory concentrations (MICs) of clinical (nail and sputum) and environmental strains. We found that six isolates with itraconazole MIC >16 mg/L demonstrated nonsynonymous mutations, including V51I, L378P, E483K, and E506G, and synonymous mutations, including F53F, A186A, Q276Q, and H359H. Moreover, P486S was detected in five strains with ITR MIC >16 mg/L. One mutation, F324S, was detected in an isolate with posaconazole MIC >16 mg/L. The effect of E483K and P486S mutations of CYP51A on azole resistance was further investigated using homology modeling and molecular dynamics. We found that E483K and P486S mutations were located near the ligand access channel of CYP51A that could partly lead to narrowing the entry of the ligand access channels. Therefore, we concluded that E483K and P486S mutations may potentially contribute to the limited access of inhibitors to the binding pocket and therefore confer resistance to azole agents.

摘要

是一种常见的环境物种,已知会导致谷物处理人员职业性过敏疾病。我们最近观察到这种真菌的唑类耐药株是甲真菌病的病因。为了进一步确定耐药的原因,我们对 9 株对伊曲康唑敏感的分离株和 6 株对临床(指甲和痰液)和环境 分离株具有高最小抑菌浓度(MIC)的分离株的编码 14α-甾醇脱甲基酶(和)的基因进行了特征描述和分析。我们发现,6 株伊曲康唑 MIC>16mg/L 的分离株表现出非同义突变,包括 V51I、L378P、E483K 和 E506G,以及同义突变,包括 F53F、A186A、Q276Q 和 H359H。此外,在 5 株 ITR MIC>16mg/L 的菌株中检测到 P486S。在 1 株 posaconazole MIC>16mg/L 的分离株中检测到 F324S 突变。使用同源建模和分子动力学进一步研究了 CYP51A 的 E483K 和 P486S 突变对唑类药物耐药性的影响。我们发现 E483K 和 P486S 突变位于 CYP51A 的配体进入通道附近,这可能导致配体进入通道变窄。因此,我们得出结论,E483K 和 P486S 突变可能导致抑制剂进入结合口袋的受限,从而导致对唑类药物的耐药性。

相似文献

1
Novel Point Mutations in and Genes Associated with Itraconazole and Posaconazole Resistance in Isolates.新型 和 基因点突变与伊曲康唑和泊沙康唑耐药的 分离株相关。
Microb Drug Resist. 2019 Jun;25(5):652-662. doi: 10.1089/mdr.2018.0300. Epub 2019 Jan 18.
2
Mutations, Extrolite Profiles, and Antifungal Susceptibility in Clinical and Environmental Isolates of the Aspergillus viridinutans Species Complex.变异性、外生代谢产物谱和临床及环境曲霉属绿僵菌种复合体分离株的抗真菌药敏性。
Antimicrob Agents Chemother. 2019 Oct 22;63(11). doi: 10.1128/AAC.00632-19. Print 2019 Nov.
3
Investigation of Azole Resistance Involving 51A and 51B Genes in Clinical Isolates.临床分离株中涉及 51A 和 51B 基因的唑类耐药性研究。
Pol J Microbiol. 2024 May 3;73(2):131-142. doi: 10.33073/pjm-2024-001. eCollection 2024 Jun 1.
4
Three-dimensional models of 14α-sterol demethylase (Cyp51A) from Aspergillus lentulus and Aspergillus fumigatus: an insight into differences in voriconazole interaction.从 lentulus 和 fumigatus 曲霉中 14α-甾醇脱甲基酶(Cyp51A)的三维模型:深入了解伏立康唑相互作用的差异。
Int J Antimicrob Agents. 2011 Nov;38(5):426-34. doi: 10.1016/j.ijantimicag.2011.06.005. Epub 2011 Aug 25.
5
cyp51A-based mechanism of azole resistance in Aspergillus fumigatus: Illustration by a new 3D Structural Model of Aspergillus fumigatus CYP51A protein.基于 Cyp51A 的烟曲霉唑类耐药机制:通过构建新型烟曲霉 Cyp51A 蛋白 3D 结构模型进行说明。
Med Mycol. 2016 May;54(4):400-8. doi: 10.1093/mmy/myv102. Epub 2016 Jan 14.
6
Surveillance for azole resistance in clinical and environmental isolates of Aspergillus fumigatus in Australia and cyp51A homology modelling of azole-resistant isolates.在澳大利亚,对烟曲霉临床和环境分离株中的唑类耐药性进行监测,以及对唑类耐药分离株进行 Cyp51A 同源建模。
J Antimicrob Chemother. 2018 Sep 1;73(9):2347-2351. doi: 10.1093/jac/dky187.
7
In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates.新型抗真菌化合物 F901318 对难治疗的曲霉属分离株的体外活性。
J Antimicrob Chemother. 2017 Sep 1;72(9):2548-2552. doi: 10.1093/jac/dkx177.
8
Species Distribution and In Vitro Azole Susceptibility of Aspergillus Section Nigri Isolates from Clinical and Environmental Settings.临床和环境来源的黑曲霉群分离株的物种分布及体外唑类药物敏感性
J Clin Microbiol. 2016 Sep;54(9):2365-72. doi: 10.1128/JCM.01075-16. Epub 2016 Jul 13.
9
Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma.从一名肺曲菌球患者连续分离出的烟曲霉中cyp51A基因的突变及其对伊曲康唑的敏感性
J Antimicrob Chemother. 2005 Jan;55(1):31-7. doi: 10.1093/jac/dkh507. Epub 2004 Nov 24.
10
First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey.在土耳其首次测定携带TR34/L98H突变的烟曲霉菌株对唑类药物的耐药性。
J Infect Chemother. 2015 Aug;21(8):581-6. doi: 10.1016/j.jiac.2015.04.012. Epub 2015 May 14.

引用本文的文献

1
Molecular epidemiology, diversity, and antifungal susceptibility profiles of clinical and environmental mucorales: a five-year multicenter study in Iran (2018-2023).临床和环境毛霉目真菌的分子流行病学、多样性及抗真菌药敏谱:伊朗一项为期五年的多中心研究(2018 - 2023年)
BMC Infect Dis. 2025 Jul 1;25(1):849. doi: 10.1186/s12879-025-11189-7.
2
is required for stress response and pathogenicity in .在……中应激反应和致病性需要…… (此句原文不完整,翻译可能不太准确,需结合完整文本理解)
Virulence. 2025 Dec;16(1):2472877. doi: 10.1080/21505594.2025.2472877. Epub 2025 Mar 9.
3
Aneuploidy Is Associated with Azole Resistance in Aspergillus fumigatus.
非整倍体与烟曲霉中唑类药物耐药性有关。
Antimicrob Agents Chemother. 2023 Apr 18;67(4):e0125322. doi: 10.1128/aac.01253-22. Epub 2023 Mar 28.
4
Acquisition of cross-azole tolerance and aneuploidy in Candida albicans strains evolved to posaconazole.白念珠菌对泊沙康唑产生交叉唑类耐药性和非整倍体的进化
G3 (Bethesda). 2022 Aug 25;12(9). doi: 10.1093/g3journal/jkac156.
5
Isoeugenol affects expression pattern of conidial hydrophobin gene RodA and transcriptional regulators MedA and SomA responsible for adherence and biofilm formation in Aspergillus fumigatus.异丁香酚影响烟曲霉分生孢子疏水性水蛋白基因 RodA 以及负责黏附与生物膜形成的转录调控因子 MedA 和 SomA 的表达模式。
Arch Microbiol. 2022 Mar 22;204(4):214. doi: 10.1007/s00203-022-02817-w.
6
A Paradigm Shift in the Treatment and Management of Onychomycosis.甲癣治疗与管理的范式转变
Skin Appendage Disord. 2021 Aug;7(5):351-358. doi: 10.1159/000516112. Epub 2021 May 11.
7
Preliminary Characterization of NP339, a Novel Polyarginine Peptide with Broad Antifungal Activity.NP339 的初步特征:一种具有广谱抗真菌活性的新型多精氨酸肽。
Antimicrob Agents Chemother. 2021 Jul 16;65(8):e0234520. doi: 10.1128/AAC.02345-20.
8
A 23 bp Promoter Deletion Associated With Voriconazole Resistance in Clinical and Environmental Isolates of .与临床和环境分离株中伏立康唑耐药性相关的23碱基对启动子缺失 。 (原文结尾处的“.”表述不完整,推测可能是某种真菌等微生物,但由于信息不足无法准确补充完整)
Front Microbiol. 2020 Mar 31;11:272. doi: 10.3389/fmicb.2020.00272. eCollection 2020.
9
Trichophyton rubrum Azole Resistance Mediated by a New ABC Transporter, TruMDR3.红色毛癣菌唑类耐药性由新型 ABC 转运蛋白 TruMDR3 介导。
Antimicrob Agents Chemother. 2019 Oct 22;63(11). doi: 10.1128/AAC.00863-19. Print 2019 Nov.
10
The Fungal CYP51s: Their Functions, Structures, Related Drug Resistance, and Inhibitors.真菌细胞色素P451:其功能、结构、相关耐药性及抑制剂
Front Microbiol. 2019 Apr 24;10:691. doi: 10.3389/fmicb.2019.00691. eCollection 2019.